OCGN

Ocugen Inc

0.9250

+0.1085+13.29%

After Hours: 0.9312 +0.0062 +0.67%19:59 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8301/0.8165

TODAY RANGE0.8250-0.9669

VOL7.47M

MARKET CAP313.86M

52 WEEK RANGE0.6909-2.725

AVG VOL (3M)6.63M

% TURNOVER2.06%

TURNOVER--

P/E (TTM)-3.6317

% RANGE17.38%

EPS(TTM)-0.2547

P/E(FORWARD)-3.5807

P/B-18.9549

BVPS-0.0488

DIVIDEND--

P/S65.60

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP309.43M

SHARES OUTSTANDING339.31M

NEXT EARNINGS03/02-03/08

FREE FLOAT334.52M

LOT SIZE1

EX-DATE09/30/2019

News

Press Releases

Financial Reports

Profile

Dow Jones·5h ago
Ocugen Inc. Stock Advances 13.3%, Outperforms Market
Dow Jones·2d ago
Ocugen Inc. Stock Rallies 17.4%, Outperforms Market
Dow Jones·2d ago
*Ocugen 3Q Loss/Shr 1c >OCGN
Dow Jones·2d ago
Press Release: Ocugen Provides Business Update with Third Quarter 2026 Financial Results
Dow Jones·2d ago
Press Release: Ocugen Provides Business Update -2-
Seeking Alpha·5d ago
My 'Eye' Is On Tarsus Pharmaceuticals
Seeking Alpha·10/29 19:44
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Dow Jones·10/27 20:34
Ocugen Inc. Stock Advances 6.9%, Outperforms Market
Dow Jones·10/26 20:34
Ocugen Inc. Stock Slides 4.2%, Underperforms Market
Dow Jones·10/20 20:35
Ocugen Inc. Stock Advances 3.9%, Outperforms Market
TipRanks·10/20 12:51
Largest borrow rate increases among liquid names
TipRanks·10/15 12:29
Ocugen Highlights Progress in Ophthalmic Gene Therapy Pipeline
TipRanks·10/15 10:30
Ocugen Licenses OCU400 Gene Therapy to Roots Pharma
Dow Jones·10/14 20:35
Ocugen Inc. Stock Slips 5.0%, Underperforms Market
NASDAQ·10/14 12:14
Ocugen Expands OCU400 Gene Therapy Reach With $255 Mln Milestone Deal

Same Industry

Name/Symbol

Change%

Price

OCGN

REGN

GRDX

BNTX

UTHR

VRTX

SIGA

Moderna

MRNA

+5.27%

254.19

CRL

MEDP

TLPH

CBPO

ICLR

IQV

MOLN

GILD

ARCT

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.